Description
What it is
A 28-amino-acid peptide isolated from the thymus gland — approved as a pharmaceutical (Zadaxin) in over 30 countries for immune research applications.
Why it’s studied
Thymosin Alpha-1 is one of the most clinically validated peptides in immune research, with over 70 clinical trials investigating its effects on T-cell function and viral response markers.
Key research findings
-
Over 70 clinical trials investigating immune function effects (Zadaxin clinical program)
-
Documented T-cell maturation and signaling effects
-
Approved pharmaceutical use in over 30 countries for immune research
